Latest news
Gyre Therapeutics Reports Second Quarter 2026 - TradingViewTradingView · Fri, 07 Aug 2026 13:04:42 GMTAtossa's Phase 2 Breast Cancer Trial Completes Enrollment - Stock TitanStock Titan · Fri, 07 Aug 2026 12:45:00 GMTAbout $300M Cullgen deal adds cancer candidates to Gyre's pipeline - Stock TitanStock Titan · Fri, 07 Aug 2026 11:00:00 GMTCognition Therapeutics Reports Financial Results for the Second Quarter 2026 and Provides Business Update - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 20:15:00 GMTRelay Therapeutics Reports Second Quarter 2026 Financial Results and Corporate Updates - GlobeNewswireGlobeNewswire · Thu, 06 Aug 2026 20:05:00 GMTPress Release: Relmada Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update - MoomooMoomoo · Thu, 06 Aug 2026 20:05:00 GMTStructure Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 20:05:00 GMTRelmada Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update - GlobeNewswireGlobeNewswire · Thu, 06 Aug 2026 20:05:00 GMT